Citigroup
IMGN

Citigroup’s Immunogen Inc IMGN Stock Holding History

Citigroup’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-337,743
Closed -$10M – 5939
2023
Q4 		$10M Buy
337,743
+92,192
+38% +$1.84M 0.01% 1223
2023
Q3 		$3.9M Buy
245,551
+50,869
+26% +$846K ﹤0.01% 1566
2023
Q2 		$3.67M Sell
194,682
-904,970
-82% -$10.7M ﹤0.01% 1702
2023
Q1 		$4.22M Buy
1,099,652
+496,726
+82% +$2.12M ﹤0.01% 1587
2022
Q4 		$2.99M Sell
602,926
-301,572
-33% -$1.64M ﹤0.01% 1773
2022
Q3 		$4.32M Buy
904,498
+101,213
+13% +$534K ﹤0.01% 1631
2022
Q2 		$3.61M Buy
803,285
+619,203
+336% +$2.69M ﹤0.01% 1722
2022
Q1 		$876K Sell
184,082
-209,933
-53% -$1.16M ﹤0.01% 3090
2021
Q4 		$2.92M Sell
394,015
-57,911
-13% -$360K ﹤0.01% 2295
2021
Q3 		$2.56M Sell
451,926
-308,643
-41% -$1.78M ﹤0.01% 2337
2021
Q2 		$5.01M Buy
760,569
+148,652
+24% +$1.04M ﹤0.01% 1889
2021
Q1 		$4.96M Buy
611,917
+427,428
+232% +$3.49M ﹤0.01% 1793
2020
Q4 		$1.19M Buy
184,489
+17,915
+11% +$104K ﹤0.01% 3370
2020
Q3 		$600K Sell
166,574
-146,859
-47% -$593K ﹤0.01% 3703
2020
Q2 		$1.44M Buy
313,433
+32,931
+12% +$140K ﹤0.01% 3168
2020
Q1 		$957K Buy
280,502
+58,020
+26% +$254K ﹤0.01% 3224
2019
Q4 		$1.14M Sell
222,482
-18,236
-8% -$61.9K ﹤0.01% 3629
2019
Q3 		$581K Sell
240,718
-55,857
-19% -$148K ﹤0.01% 4201
2019
Q2 		$643K Buy
296,575
+204,474
+222% +$484K ﹤0.01% 4163
2019
Q1 		$250K Sell
92,101
-430,608
-82% -$1.87M ﹤0.01% 4886
2018
Q4 		$2.51M Buy
522,709
+417,739
+398% +$2.53M ﹤0.01% 2453
2018
Q3 		$994K Buy
104,970
+36,147
+53% +$347K ﹤0.01% 3508
2018
Q2 		$670K Sell
68,823
-238,849
-78% -$2.52M ﹤0.01% 3785
2018
Q1 		$3.24M Sell
307,672
-142,763
-32% -$1.41M ﹤0.01% 2165
2017
Q4 		$2.89M Buy
450,435
+207,007
+85% +$1.28M ﹤0.01% 2321
2017
Q3 		$1.86M Sell
243,428
-396
-0.2% -$2.63K ﹤0.01% 2727
2017
Q2 		$1.73M Buy
243,824
+140,433
+136% +$643K ﹤0.01% 2736
2017
Q1 		$400K Sell
103,391
-100,302
-49% -$293K ﹤0.01% 4058
2016
Q4 		$416K Buy
203,693
+42,129
+26% +$84.6K ﹤0.01% 4569
2016
Q3 		$433K Sell
161,564
-3,431
-2% -$9.98K ﹤0.01% 4026
2016
Q2 		$508K Sell
164,995
-1,214
-0.7% -$7.61K ﹤0.01% 3641
2016
Q1 		$1.42M Buy
166,209
+56,324
+51% +$477K ﹤0.01% 2922
2015
Q4 		$1.49M Sell
109,885
-50,832
-32% -$626K ﹤0.01% 2727
2015
Q3 		$1.54M Buy
160,717
+21,153
+15% +$309K ﹤0.01% 2688
2015
Q2 		$2.01M Sell
139,564
-11,974
-8% -$132K ﹤0.01% 2508
2015
Q1 		$1.36M Buy
151,538
+51,904
+52% +$376K ﹤0.01% 2820
2014
Q4 		$608K Buy
99,634
+34,066
+52% +$312K ﹤0.01% 3676
2014
Q3 		$695K Buy
65,568
+16,984
+35% +$192K ﹤0.01% 3285
2014
Q2 		$575K Sell
48,584
-4,006
-8% -$50.3K ﹤0.01% 3364
2014
Q1 		$785K Sell
52,590
-16,052
-23% -$253K ﹤0.01% 3076
2013
Q4 		$1.01M Buy
68,642
+21,974
+47% +$338K ﹤0.01% 3176
2013
Q3 		$795K Buy
46,668
+11,673
+33% +$205K ﹤0.01% 3076
2013
Q2 		$580K Buy
+34,995
New +$567K ﹤0.01% 3354

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Citigroup's IMGN Position: Q1 2024 in Review

Citigroup sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 337,743 shares — an estimated $10M sold.

Citigroup first reported a position in IMGN in Q2 2013 and held it in 43 quarters. The position peaked at $10M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Citigroup reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Citigroup sold 337,743 Immunogen Inc shares in Q1 2024, an estimated $10M.
  • Citigroup first reported a position in Immunogen Inc in Q2 2013 and held it in 43 quarters.
  • Citigroup's Immunogen Inc position peaked at $10M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Citigroup's 13F filing for Q1 2024, filed 10 May 2024.